Rankings
▼
Calendar
SMMT FY 2020 Earnings — Summit Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
SMMT
Summit Therapeutics Inc.
$12B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$860,000
Gross Profit
$860,000
100.0% margin
Operating Income
-$53M
-6185.2% margin
Net Income
-$53M
-6127.6% margin
EPS (Diluted)
$-0.76
Cash Flow
Operating Cash Flow
-$48M
Free Cash Flow
-$49M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$102M
Total Liabilities
$23M
Stockholders' Equity
$79M
Cash & Equivalents
$66M
← Q1 2020
All Quarters